
David H. Willse
Examiner (ID: 11336, Phone: (571)272-4762 , Office: P/3738 )
| Most Active Art Unit | 3738 |
| Art Unit(s) | 2899, 3302, 3308, 3738, 3774 |
| Total Applications | 1966 |
| Issued Applications | 1289 |
| Pending Applications | 211 |
| Abandoned Applications | 487 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7349429
[patent_doc_number] => 20040047885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter'
[patent_app_type] => new
[patent_app_number] => 10/613723
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3174
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613723 | Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter | Jul 6, 2003 | Abandoned |
Array
(
[id] => 707973
[patent_doc_number] => 07060730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Rapidly absorbed liquid compositions'
[patent_app_type] => utility
[patent_app_number] => 10/608170
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3033
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10608170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/608170 | Rapidly absorbed liquid compositions | Jun 25, 2003 | Issued |
Array
(
[id] => 7362031
[patent_doc_number] => 20040091507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Rapidly absorbed liquid compositions'
[patent_app_type] => new
[patent_app_number] => 10/607889
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3008
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10607889
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/607889 | Rapidly absorbed liquid compositions | Jun 25, 2003 | Abandoned |
Array
(
[id] => 7460631
[patent_doc_number] => 20040052837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Lipid conjugated anti-cancer drugs and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/602978
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9190
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602978
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602978 | Lipid conjugated anti-cancer drugs and methods of use thereof | Jun 23, 2003 | Abandoned |
Array
(
[id] => 7256082
[patent_doc_number] => 20040259809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/463556
[patent_app_country] => US
[patent_app_date] => 2003-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5965
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10463556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/463556 | Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof | Jun 16, 2003 | Abandoned |
Array
(
[id] => 7593162
[patent_doc_number] => 07652039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => 'Methods of use and compositions for the diagnosis and treatment of infectious disease'
[patent_app_type] => utility
[patent_app_number] => 10/441272
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 25
[patent_no_of_words] => 8202
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/652/07652039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441272 | Methods of use and compositions for the diagnosis and treatment of infectious disease | May 18, 2003 | Issued |
Array
(
[id] => 6808666
[patent_doc_number] => 20030198605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Light-activated tooth whitening composition and method of using same'
[patent_app_type] => new
[patent_app_number] => 10/434597
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14964
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20030198605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434597 | Light-activated tooth whitening composition and method of using same | May 8, 2003 | Abandoned |
Array
(
[id] => 7351371
[patent_doc_number] => 20040248820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Methods and compositions for inhibition of angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/430892
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9396
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10430892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/430892 | Methods and compositions for inhibition of angiogenesis | May 4, 2003 | Abandoned |
Array
(
[id] => 7395760
[patent_doc_number] => 20040022789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods and compositions for treating T cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency'
[patent_app_type] => new
[patent_app_number] => 10/427683
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29910
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20040022789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10427683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/427683 | Methods and compositions for treating T cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency | Apr 30, 2003 | Abandoned |
Array
(
[id] => 6640875
[patent_doc_number] => 20030212142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder'
[patent_app_type] => new
[patent_app_number] => 10/425375
[patent_app_country] => US
[patent_app_date] => 2003-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2394
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425375 | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | Apr 27, 2003 | Abandoned |
Array
(
[id] => 7136084
[patent_doc_number] => 20050181066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency'
[patent_app_type] => utility
[patent_app_number] => 10/512547
[patent_app_country] => US
[patent_app_date] => 2003-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10461
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512547 | Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency | Apr 23, 2003 | Abandoned |
Array
(
[id] => 7367984
[patent_doc_number] => 20040092532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Use of p38 inhibitors for the treatment of smoke inhalation'
[patent_app_type] => new
[patent_app_number] => 10/399580
[patent_app_country] => US
[patent_app_date] => 2003-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5229
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399580 | Use of p38 inhibitors for the treatment of smoke inhalation | Apr 17, 2003 | Abandoned |
Array
(
[id] => 6805473
[patent_doc_number] => 20030232867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Use'
[patent_app_type] => new
[patent_app_number] => 10/414150
[patent_app_country] => US
[patent_app_date] => 2003-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4694
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414150 | Use | Apr 15, 2003 | Abandoned |
Array
(
[id] => 6865662
[patent_doc_number] => 20030191188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Method for treating migraine symptoms with ibuprofen and salts thereof'
[patent_app_type] => new
[patent_app_number] => 10/412861
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1030
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412861 | Method for treating migraine symptoms with ibuprofen and salts thereof | Apr 13, 2003 | Abandoned |
Array
(
[id] => 840493
[patent_doc_number] => 07390823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-24
[patent_title] => 'Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders'
[patent_app_type] => utility
[patent_app_number] => 10/409504
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1642
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/390/07390823.pdf
[firstpage_image] =>[orig_patent_app_number] => 10409504
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/409504 | Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders | Apr 7, 2003 | Issued |
Array
(
[id] => 6629596
[patent_doc_number] => 20030211179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for improving psyllium functionality by solid-state reaction(s)'
[patent_app_type] => new
[patent_app_number] => 10/344049
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5222
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344049 | Method for improving psyllium functionality by solid-state reaction(s) | Apr 6, 2003 | Abandoned |
Array
(
[id] => 6865538
[patent_doc_number] => 20030191064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Methods for preventing and treating loss of balance function due to oxidative stress'
[patent_app_type] => new
[patent_app_number] => 10/401682
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8434
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10401682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/401682 | Methods for preventing and treating loss of balance function due to oxidative stress | Mar 30, 2003 | Abandoned |
Array
(
[id] => 738139
[patent_doc_number] => 07034159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/400890
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 10777
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10400890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/400890 | Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient | Mar 26, 2003 | Issued |
Array
(
[id] => 7679075
[patent_doc_number] => 20030195261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Methods of treating or preventing erectile dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/395298
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16462
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10395298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/395298 | Methods of treating or preventing erectile dysfunction | Mar 24, 2003 | Issued |
Array
(
[id] => 5242861
[patent_doc_number] => 20070021356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Preemptive prophlyaxis of migraine'
[patent_app_type] => utility
[patent_app_number] => 10/569148
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2678
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569148 | Preemptive prophlyaxis of migraine | Mar 13, 2003 | Abandoned |